2 unknown, 1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Adrenal Carcinoma: new trials by email Literature Review of Adrenal Carcinoma trials Research Report on Adrenal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| China Adrenal Disease Registry Cushing Syndrome, Aldosteronism | Unknown | Shanghai Jiao Tong University School of Medicine | 2000 | 2021-06-01 | 2022-02-14 | |
| VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma VETC evaluation - Renal Cell Carcinoma, Adrenal Carcinoma | Unknown | Humanitas Clinical and Research Center | 180 | 2021-01-02 | 2021-02-12 | |
| Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Osilodrostat - Cushing's Syndrome, Ectopic Corticotropin Syndrome | Phase 2 | Completed | Novartis Pharmaceuticals | 9 | 2015-09-24 | 2020-05-06 |
Adrenal Cortex Neoplasms (3) · ACTH Syndrome, Ectopic (2) · Cushing Syndrome (2) · Acth-Independent Macronodular Adrenal Hyperplasia (1) · Adrenal Hyperplasia, Congenital (1) · Adrenal Insufficiency (1) · Adrenal incidentaloma (1) · Carcinoma, Renal Cell (1) · Hyperaldosteronism (1) · Pheochromocytoma (1)
Adrenal Cortex Diseases (3) · Adrenal Gland Diseases (3) · Adrenal Gland Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Adrenocortical Hyperfunction (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms by Histologic Type (2) · Paraneoplastic Endocrine Syndromes (2) · Paraneoplastic Syndromes (2) · Urogenital Diseases (2)
Osilodrostat (1)
Humanitas Clinical and Research Center (1) · Novartis Pharmaceuticals (1) · Shanghai Jiao Tong University School of Medicine (1)
China (1) · Italy (1) · Japan (1)